Aug 19, 2020 / 06:30AM GMT
Jethro Holter - ArcticZymes Technologies ASA - CEO
Okay. So I'm going to kick off now. So welcome to the Q2 presentation. Since this is a virtual meeting, we have muted everybody's microphones, and we will unmute those at the end for the Q&A session. So today, it's myself, Jethro Holter, CEO; and Børge Sørvoll, our CFO, will walk you through the presentation today.
Today actually marks a new era for us. It's the first time we actually present as ArcticZymes Technologies. We rebranded the company from Biotec Pharmacon to ArcticZymes Technologies back in June. We are very proud of the new brand. It fits seamlessly and resonates well with our commitment to the enzyme business being our core future focus moving forward.
So with the new brand, we have a clear mission and vision. So our vision is, with our daily work, we want to make an important contribution to a healthier world. Driven by this goal, our experienced scientists are constantly working to find and unlock new solutions. What this essentially means is at the end of the day, for us, it's more of enzymes. We want to improve
Q2 2020 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers